Survival Analysis of Patients with Beta-Thalassemia Major in Isfahan Province

Authors

  • Ali Azarbar * Department of Statistics, University of Urmia, Urmia, Iran.

https://doi.org/10.22105/ahse.v2i4.51

Abstract

Beta-thalassemia major is one of the most prevalent forms of anemia that has become increasingly widespread in recent years. If not diagnosed and managed in a timely manner, the disease may lead to patient mortality. The application of appropriate statistical models, such as survival analysis in affected patients, can provide an effective approach for identifying and determining the factors influencing the risk of death among these patients. The present study aimed to identify the best-fitting survival model, using conventional survival analysis methods, to determine the risk factors associated with mortality in patients with beta-thalassemia major. This study utilized data from 190 patients with beta-thalassemia major who attended a treatment center in Isfahan between 2011 and 2021. Using the R statistical software, exponential, Weibull, log-normal, log-logistic, and Gompertz models—with and without frailty terms—as well as the semi-parametric Cox model were fitted to the data. Based on the Akaike Information Criterion (AIC) and a significance level of 0.05, the log-normal model was identified as the best-fitting model, whereas the Gompertz model demonstrated the poorest fit. Accordingly, the parametric log-normal model was selected and recommended for the survival analysis of beta-thalassemia major, and the effects of the relevant variables were subsequently estimated.

Keywords:

Beta-thalassemia major, Survival analysis, Log-normal model, Cox model, Akaike information criterion

References

  1. [1] Latifi, S. M., & Zandian, K. (2010). Survival analysis of β-thalassemia major patients in Khouzestan province referring to Shafa hospital. Scientific medical journal (AJUMS), 9(1), 83–92. http://smj.ajums.ac.ir/index.php/MainJournal/issue/archive

  2. [2] Ansari, H., & Tabatabaei, S. (2006). Assessment of survival without cardiac disease of thalassemic patients of Shiraz, Iran, 2005. Zahedan journal of research in medical sciences, 8(1), e94917. https://brieflands.com/journals/zjrms/articles/94917

  3. [3] Moayeri, H., & Oloomi, Z. (2006). Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Archives of Iranian medicine, 9(4), 329-34. https://pubmed.ncbi.nlm.nih.gov/17061604/

  4. [4] Henderson, R. (1995). Problems and prediction in survival-data analysis. Statistics in medicine, 14(2), 161–184. https://doi.org/10.1002/sim.4780140208

  5. [5] Rosthøj, S., & Keiding, N. (2004). Explained variation and predictive accuracy in general parametric statistical models: The role of model misspecification. Lifetime data analysis, 10(4), 461–472. https://doi.org/10.1007/s10985-004-4778-6

  6. [6] Kleinbaum, D. G., & Klein, M. (1996). Survival analysis a self-learning text. Springer. https://doi.org/10.1007/0-387-29150-4

  7. [7] Biglarian, A., Bakhsi, E., Rahgozar, M., Karimloo, M. (2011). Comparison of artificial neural network and logistic regression in predicting of binary response for medical data the stage of disease in gastric cancer. Journal of north Khorasan university of medical sciences, 3(5), 15–21. https://doi.org/10.29252/jnkums.3.5.S5.15

  8. [8] Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M. D., Del Vecchio, G. C., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., Piga, A., & Cnaan, A. (2004). Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica journal, 89(10), 1187–1193. https://haematologica.org/article/view/3248

  9. [9] Roudbari, M., Soltani-Rad, M., & Roudbari, S. (2008). The survival analysis of beta thalassemia major patients in South East of Iran. Saudi medical journal, 29(7), 1031–1035. https://doi.org/10.15537/1658-3175.4401

  10. [10] Ladis, V., Chouliaras, G., Berdousi, H., Kanavakis, E., & Kattamis, C. (2005). Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Annals of the new york academy of sciences, 1054(1), 445–450. https://doi.org/10.1196/annals.1345.067

  11. [11] Yavarian, M., Farsheedfar, G. R., Karimi, M., Almoazzez, M., Harteveld, C. L., & Giordano, P. C. (2006). Survival analysis of transfusion dependent β-Thalassemia major patients. Journal of research in health sciences, 6(2), 8-13. https://pubmed.ncbi.nlm.nih.gov/15477200/

Published

2025-12-13

How to Cite

Azarbar, A. (2025). Survival Analysis of Patients with Beta-Thalassemia Major in Isfahan Province. Annals of Healthcare Systems Engineering, 2(4), 233-238. https://doi.org/10.22105/ahse.v2i4.51

Similar Articles

1-10 of 23

You may also start an advanced similarity search for this article.